0001171843-15-003459.txt : 20150616
0001171843-15-003459.hdr.sgml : 20150616
20150616170257
ACCESSION NUMBER: 0001171843-15-003459
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150615
FILED AS OF DATE: 20150616
DATE AS OF CHANGE: 20150616
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNOMEDICS INC
CENTRAL INDEX KEY: 0000722830
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 611009366
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
BUSINESS PHONE: 9736058200
MAIL ADDRESS:
STREET 1: 300 AMERICAN ROAD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOLDENBERG CYNTHIA L
CENTRAL INDEX KEY: 0001202016
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12104
FILM NUMBER: 15934984
MAIL ADDRESS:
STREET 1: C/O XIMMUNOMEDICS INC
STREET 2: 300 AMERICAN RD
CITY: MORRIS PLAINS
STATE: NJ
ZIP: 07950
FORMER NAME:
FORMER CONFORMED NAME: SULLIVAN CYNTHIA L
DATE OF NAME CHANGE: 20021029
4
1
gff4_cynthiagoldenberg061615.xml
OWNERSHIP DOCUMENT
X0306
4
2015-06-15
0
0000722830
IMMUNOMEDICS INC
IMMU
0001202016
GOLDENBERG CYNTHIA L
C/O IMMUNOMEDICS, INC.
300 AMERICAN ROAD
MORRIS PLAINS
NJ
07950
1
1
0
0
President and CEO
Common Stock
2015-06-15
4
M
0
70297
1.75
A
579854
D
Common Stock
2015-06-15
4
S
0
38248
4.1225
D
541606
D
Common Stock
2015-06-15
4
M
0
150000
1.75
A
5431417
I
See footnote
Common Stock
2015-06-15
4
S
0
82077
4.069
D
5349340
I
See footnote
Common Stock
2015-06-15
4
M
0
120050
2.67
A
5469390
I
See footnote
Common Stock
2015-06-15
4
S
0
90666
4.069
D
5378724
I
See footnote
Stock Option (right to buy)
1.75
2015-06-15
4
M
0
70297
0
A
2015-06-15
Common Stock, par value $0.01 per share
70297
0
D
Stock Option (right to buy)
1.75
2015-06-15
4
M
0
150000
0
A
2015-06-15
Common Stock, par value $0.01 per share
150000
0
I
See footnote
Stock Option (right to buy)
2.67
2015-06-15
4
M
0
120050
0
A
2015-07-18
Common Stock, par value $0.01 per share
120050
0
I
See footnote
Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer and Chairman of the Board of Directors.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.09 to $4.16.
The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein.
The price in column 4 is a weighted average price. The prices actually received in this transaction range from $4.03 to $4.1625.
The reporting person's spouse has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested immediately.
These stock options were granted pursuant to the Issuer's 2006 Stock Incentive Plan, and vested 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter.
The reporting person's spouse was granted these stock options pursuant to the Issuer's 2006 Stock Incentive Plan.
/s/ Cynthia L. Goldenberg
2015-06-16